Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    21916639 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response
Condition: Hepatitis C
Interventions: Drug: telaprevir;   Drug: ribavirin;   Biological: peginterferon alfa-2a
2 Completed Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir
Conditions: Hepatitis C, Chronic;   Cirrhosis
Interventions: Drug: Telaprevir;   Drug: Boceprevir;   Drug: Peg-IFN;   Drug: Ribavirin

Study has passed its completion date and status has not been verified in more than two years.